N/A N=133 Modulation of Spontaneous Cortical Activity by tDCS: BRAIN Initiative I
Brain Function
Primary: Behavioral Performance (Accuracy) on Cognitive Tests of Perceptual Processing — 97; 98; 98 percent correct
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=246 Platelet Activity in Vascular Surgery and Cardiovascular Events
Cardiovascular Disease · Peripheral Artery Disease · Critical Limb Ischemia
Primary: Number of Patients in Which Platelet Activity Measurements Were Associated With Short-term Cardiovascular Events — 31; 16 participants
N/A N=61 COVID-19 Screening Program
COVID-19
Primary: Use of a Voluntary COVID-19 Point of Care (POC) Screening Program — 238 total completed screening tests reported
N/A N=9 Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses
Refractive Errors · Presbyopia · Astigmatism
Primary: Mean Distance Visual Acuity (VA) With Study Lenses — -0.04; -0.09 logMAR
N/A N=30 Use of Continuous Glucose Monitors in Publicly-Insured Youth With Type 2 Diabetes - A Pilot and Feasibility Study
Type 2 Diabetes
Primary: Number of Participants With at Least 75% Wear Time Over 14 Days as a Measure of Sustained CGM Use — 7; 2; 1; 0 Participants
N/A N=90 Self-monitoring Activity: a Randomized Trial of Game-oriented Applications
Breast Cancer · Obesity
Primary: Change in Minutes Per Day of Physical Activity — 20.87; 15.82 minutes per day — p=.35
N/A N=98 Dual-plane Ultrasound Imaging During Vascular Access Procedures
Vascular Access Complication
Primary: Time to Successful First Stick in Minutes — 4.56; 6.24 minutes
Phase 3 N=3,900 A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals
Healthy
Primary: Number of Participants With Confirmed Human Immunodeficiency Virus (HIV)-1 Infections Diagnosed Between the Month 7 and Month 24 Visits (Per-protocol [PP] Set) — 65; 58…
N/A N=81 Effect of Increased Fruit and Vegetable Intake on Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease
Primary: Self-reported Intake of Fruit and Vegetables (Number of Portions Per Day); — 1.9; 6.1 Portions per day
Phase 1 N=6 A Study in Healthy Adult Male Participants to Assess Absorption, Distribution, Metabolism and Excretion (ADME) of Radiolabeled PF-06865571.
Healthy Participants
Primary: Total Recovery of Radioactivity in Urine as Percentage of Total Radioactive Dose of PF-06865571 Administered — 48.9; 51.5 Percentage of Dose
N/A N=66 AIM1: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid
Thyroid Nodules · Thyroid Cancer
Primary: Qualitative Analysis of the Patient and Clinician Experience Using the Conversation Aid — 12; 0; 12; 0 Participants
Phase 2 N=122 Bryostatin Treatment of Moderately Severe Alzheimer's Disease
Alzheimer Disease
Primary: Safety: Treatment-emergent Adverse Events and Serious Adverse Events for All Randomized Subjects Who Received Any Study Medication — 15; 13; 4; 4 number of events
N/A N=2,591 Project RESIST: Evaluating the Effects of Anti-smoking Inoculation Messages Among Young Adult Sexual Minority Women
Cigarette Smoking Behavior
Primary: Intention to Quit Smoking at Follow-up — 11.8; 11.0; 14.4; 9.9 units on a scale
Phase 2 N=130 A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection
Hepatitis B, Chronic
Primary: Percentage of Participants With Hepatitis B Surface Antigen (HBsAg) Seroclearance at Week 72 Without Restarting NA Treatment — 0.0; 0.0 Percentage of participants
N/A N=223 Bloodsafe Ghana- Iron and Nutritional Counseling Strategy Pilot Study
Iron-deficiency Anemia · Iron-deficiency
Primary: Haemoglobin Level — 11.35; 12.28 g/dL — p=0.025